When Clinical Trials Try Patients' Patience
November 01, 2018 – Ellen Miller-Sonet
Survivors and Healers
October 18, 2018 – Geoffrey Norman
Fufilling My Life Purpose
October 10, 2018 – Brian Kudler
Finding My Gift Through My Breast Cancer Journey
October 05, 2018 – Tara Dunsmore
Survivor's Guilt
September 26, 2018 – Michelle Burleigh
Myeloma Link: Empowering African Americans
September 18, 2018 – Mel Mann
Thriving Through October Together
September 17, 2018 – Martha L. Van Dam, M.S., LMHC, NCC
Talking With a Therapist Can Ease Cancer-Related Fears
September 13, 2018 – Maya Harsaniova
Superman, Sort Of
September 12, 2018 – Stephen Labay
Family Caregivers: The 'Pseudo' Doctors and Nurses
September 11, 2018 – Debi Boyle MSN, RN, AOCNS, FAAN

A Cancer Foundation Grows From a Sentiment That Takes Root

Before losing her battle to ovarian cancer, Julie Paige McAvinn wanted to make sure other women were better educated about female cancers. Keeping his promise to his late wife, Peter McAvinn created the Julie Fund.
BY Tony Hagen
PUBLISHED March 07, 2016
It was one of those things in life that happens when you think you’ve got things pretty well squared away. It was the summer of 2004, and odd things were happening with Julie Paige McAvinn’s body.  The 40-year-old mother of three young children, each under the age of 10, just didn’t feel like her old self.
 
She had a little lower back pain, some bloating, and other things. These symptoms were enough to send her to the doctor, who saw nothing particularly unusual, especially for a woman who was raising children. “It’s just part of life,” she was told.
 
So, Julie went back to the business of motherhood, but she still didn’t feel great, and that led her to seek further medical attention. It wasn’t until the fall of that year that she received her diagnosis of stage 4 ovarian cancer. This highly aggressive disease had snuck up on her and taken full control of her health.
 
Within four months she was gone from this life, but before she left she had a serious talk with her husband, Peter. She made him promise to do everything in his power to help other women like her, to educate them, so that they would know how to distinguish the warning signs of female cancers — how to become more aware of what their bodies are telling them — and what to do about it.
 
Out of that talk was born The Julie Fund, which is dedicated to helping women who find themselves faced with one or more of the big five: breast, ovarian, cervical, uterine, vagina and vulvar cancers.
 
The Julie Fund is about education, arming women with knowledge. It’s about non-medical patient and family financial support — so that such basics as housing, transportation, food and day care are provided for. And it’s about funding female cancer research — so that one day, tools and knowledge will be available for a more successful battle against female cancer.
 
From those beginnings, The Julie Fund has grown into a well-organized foundation that has become the largest single philanthropic donor for gynecologic cancer research at the nationally renowned Massachusetts General Hospital.
 
After 11 years of community based support, The Julie Fund has raised over $3.5 million to carry out its mission. And while its philosophy of giving to support the welfare of female cancer victims continues to envelope the five major female cancer groups, research efforts are focused on ovarian cancer.
 
Executive Director Cheryl LaMee explains that when The Julie Fund came into being, there wasn’t all that much money going into ovarian research.
 
“There was a lot of money being invested in breast cancer; and being a small, grassroots organization, we thought that the best use of the funding that we had was to put it toward ovarian.” It wasn’t a minor consideration, also, that Julie Paige McAvinn died of ovarian cancer.
 
At Massachusetts General Hospital, the foundation’s money set aside for ovarian research is going into the following three areas:
  • Research to identify blood markers, which can detect early stage ovarian cancer.
  • Development of gene tests that can determine which women in early stage will have a recurrence of cancer after initial treatment.  This test is similar to the test used for detection of early stage breast cancer (Oncotype DX).
  • Research to determine the molecular basis for platinum resistant ovarian cancer, the most deadly form of ovarian cancer. This project uses cutting-edge technology to determine the most precise therapy for a cancerous tumor.
  • The Julie Fund’s mission to provide financial support for essentials during cancer treatment forms the second leg of the stool; and its third major activity, education, involves a focus not only on what women cancer patients need to know but also what mothers need to tell their daughters about proper awareness and resources available for cancer prevention.
    For readers of CURE, The Julie Fund put together this “Top 12” list of questions that women with cancer need to ask their providers and social workers in order to be best informed about how to respond to their diagnosis.
    1. Where can I find more information about my diagnosis, my treatment, and how to cope?
    2. Should I get a second opinion?
    3. What are my treatment choices and side effects?
    4. Are clinical trials an option for me?
    5. How can I deal with my fear and anxiety?
    6. What do I say to my family and friends?
    7. How do I get information on advanced care planning and a health care proxy?
    8. What if I have financial or insurance concerns?
    9. Can I talk with someone who has been through this before?
    10. What happens when my treatment ends?
    11. How do I learn about integrative/complementary therapies?
    12. How will I balance cancer care with the demands of my normal life?

    To find out more about The Julie Fund, or to make a donation to this cause, visit juliefund.org.
     
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the Ovarian Cancer CURE discussion group.

Related Articles

$articleRelated$
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In